rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-6-14
|
pubmed:abstractText |
Given the few controversial data about the effect of highly active antiretroviral therapy (HAART) on bone mass in HIV patients, we investigated whether a relationship between osteopenia/osteoporosis risk and HAART exists.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1824-4785
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-48
|
pubmed:dateRevised |
2005-12-20
|
pubmed:meshHeading |
pubmed-meshheading:15195003-Adult,
pubmed-meshheading:15195003-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15195003-Biological Markers,
pubmed-meshheading:15195003-Bone Density,
pubmed-meshheading:15195003-Bone Diseases, Metabolic,
pubmed-meshheading:15195003-Bone Remodeling,
pubmed-meshheading:15195003-Female,
pubmed-meshheading:15195003-HIV Infections,
pubmed-meshheading:15195003-Humans,
pubmed-meshheading:15195003-Male,
pubmed-meshheading:15195003-Middle Aged,
pubmed-meshheading:15195003-Osteoporosis,
pubmed-meshheading:15195003-Vitamin D
|
pubmed:year |
2004
|
pubmed:articleTitle |
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy.
|
pubmed:affiliation |
Department of Infectious Diseases, University of Sassari, Sassari, Italy.
|
pubmed:publicationType |
Journal Article
|